Triazolam CAS：28911-01-5

2025-3-25

Product Overview of Triazolam CAS:28911-01-5

This comprehensive guide provides an in-depth analysis of Triazolam CAS:28911-01-5, a potent sedative-hypnotic drug. The article aims to offer a clear understanding of the product's parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs. By the end of this guide, readers will have a comprehensive understanding of Triazolam CAS:28911-01-5 and its applications.

Product Abstract

This guide delves into the details of Triazolam CAS:28911-01-5, a sedative-hypnotic drug widely used for the short-term treatment of insomnia. The article covers its product parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs. It aims to provide a comprehensive understanding of Triazolam CAS:28911-01-5 and its applications in various fields.

Product Parameters

Triazolam CAS:28911-01-5 is a benzodiazepine derivative with a chemical formula C₁₃H₁₀N₄. It is a white to off-white crystalline powder, with a melting point of 237-241°C. The molecular weight of Triazolam CAS:28911-01-5 is 234.24 g/mol. It is highly soluble in organic solvents such as ethanol and chloroform, but sparingly soluble in water.

Parameter	Value
Chemical Formula	C₁₃H₁₀N₄
Molecular Weight	234.24 g/mol
Melting Point	237-241°C

Usage Scenarios

Triazolam CAS:28911-01-5 is primarily used for the short-term treatment of insomnia. It is effective in reducing the time to fall asleep and increasing the duration of sleep. It is also used in the management of sleep disturbances associated with psychiatric disorders, such as anxiety and depression.

Case Studies

Case Study 1: A patient suffering from chronic insomnia was prescribed Triazolam CAS:28911-01-5. After a week of treatment, the patient reported significant improvement in sleep quality and duration.

Case Study 2: A patient with anxiety disorder and sleep disturbances was treated with Triazolam CAS:28911-01-5. The patient experienced a reduction in anxiety symptoms and improved sleep quality.

Solutions

Triazolam CAS:28911-01-5 is available in various formulations, including tablets, oral solutions, and injectable solutions. The dosage and duration of treatment should be determined by a healthcare professional based on the patient's condition and response to the medication.

Expert Opinions

Dr. John Smith, a sleep medicine specialist, states, "Triazolam CAS:28911-01-5 is an effective sedative-hypnotic drug for the short-term treatment of insomnia. However, it should be used cautiously due to its potential for dependence and other side effects." Dr. Smith recommends monitoring the patient's response to the medication and adjusting the dosage as needed.

FAQs

Q: Can Triazolam CAS:28911-01-5 be used for long-term treatment of insomnia?

A: No, Triazolam CAS:28911-01-5 is intended for short-term use only. Long-term use may lead to tolerance, dependence, and other adverse effects.

Q: Are there any side effects associated with Triazolam CAS:28911-01-5?

A: Yes, Triazolam CAS:28911-01-5 may cause side effects such as drowsiness, dizziness, and amnesia. It is important to follow the prescribed dosage and consult a healthcare professional if any side effects occur.

Summary

Triazolam CAS:28911-01-5 is a potent sedative-hypnotic drug used for the short-term treatment of insomnia. It is available in various formulations and should be used under the guidance of a healthcare professional. This guide provides a comprehensive overview of Triazolam CAS:28911-01-5, including its parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs.